latest news releases from the newsroom
Theravance to Present At the Cowen and Company 29th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 3, 2009 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at the Cowen and Company 29th Annual Health Care Conference on Tuesday, March 17, 2009, at 10:15 a.m. EDT. The conference will be held from March 16-19, 2009 at the Boston Marriott Copley Place in Massachusetts.
STEC to Webcast Conference Call Discussing Fourth-Quarter and Full-Year 2008 Results
SANTA ANA, Calif., March 3, 2009 (GLOBE NEWSWIRE) -- STEC, Inc. (Nasdaq:STEC) today scheduled its earnings release and an open web cast conference call to discuss its results for the fourth quarter and full-year ended December 31, 2008. A news release discussing the Company's performance during this quarter and the year will be issued just after the market close on March 12, 2009. The web cast conference call will take place that same day at approximately 1:30 p.m., Pacific/4:30 p.m., Eastern.
LeMaitre Vascular, Inc.
LeMaitre Vascular Q4 2008 Sales Up 9% to $12.1 Million; Op. Profit of $354,000
BURLINGTON, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today announced Q4 and full year 2008 financial results. The Company also announced it has entered into a definitive agreement with Edwards Lifesciences to terminate their distribution of the Company's AlboGraft polyester grafts.
Advanced Battery Technologies, Inc.
Advanced Battery Technologies Announces Management Change
NEW YORK and HARBIN, China, March 3, 2009 (GLOBE NEWSWIRE) -- Advanced Battery Technologies, Inc. (Nasdaq:ABAT) ("the Company"), a leading developer, manufacturer and distributor of rechargeable Polymer Lithium-Ion (PLI) batteries, today announced that Taylor Zhang, the Company's Chief Financial Officer, is leaving the company for personal reasons. Mr. Zhang will continue to serve as a consultant on a part-time basis.
Noven Pharmaceuticals, Inc.
Noven to Present At Barclays Capital Global Healthcare Conference
MIAMI, March 3, 2009 (GLOBE NEWSWIRE) -- Noven Pharmaceuticals, Inc. (Nasdaq:NOVN) today announced that Peter Brandt, Noven's President & Chief Executive Officer, is scheduled to present an update on Noven's business and prospects at the Barclays Capital Global Healthcare Conference in Miami Beach on Wednesday, March 11th at 11:15 a.m. ET. The presentation will be webcast live at www.noven.com, and a rebroadcast will be available thereafter for at least two weeks at the same site.
Aastrom Biosciences, Inc.
FDA Removes Clinical Hold From Aastrom Phase II IMPACT-DCM Clinical Trial
ANN ARBOR, Mich., March 3, 2009 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today reported that the U.S. Food and Drug Administration (FDA) has removed the clinical hold from the Company's U.S. Phase II IMPACT-DCM clinical trial and that patient enrollment would resume at the four initiated clinical sites. The IMPACT-DCM trial is evaluating the use of Cardiac Repair Cells (CRCs), a mixture of stem and progenitor cells derived from a patient's own bone marrow, for the treatment of dilated cardiomyopathy (DCM), a severe form of chronic heart failure.